📂 Drugs
amivantamab — Definition
amivantamab / amivantamab
Amivantamab is a human monolonal antibody, targeting epidermal growth factor receptor (EGFR) and MET receptor tirozin kinasis. In particular, EGFR is used in the treatment of non-cellular lung cancer (KHDAK), which has 20 insertion mutations, local hands, or metastatic small cellar. This drug activates the immune system to prevent the growth and spread of tumor cells and applies signal inhibition directly to tumor cells. Amivantamab is indicated in patients who have already received platin-based chemotherapy.
Frequently Asked Questions
❓ What is amivantamab?
amivantamab; amivantamab is a human monolonal antibody, targeting epidermal growth factor receptor (EGFR) and MET receptor tirozin kinasis. In particular, EGFR is used in the treatment of non-cellular lung cancer (KHDAK), which has 20 insertion mutations, local hands, or metastatic small cellar. This drug activates the immune system to prevent the growth and spread of tumor cells and applies signal inhibition directly to tumor cells. Amivantamab is indicated in patients who have already received platin-based chemotherapy.
❓ What is amivantamab in Turkish?
The Turkish equivalent of "amivantamab" is amivantamab.
❓ Which medical field is amivantamab related to?
This term belongs to the Drugs category.